SEC 13F Intelligence

BIOMARIN PHARMACEUTICAL INC

CUSIP 09061GAH4

Biomarin Pharmaceutical Inc has 47 institutional holders in Filings Flow’s 13F database, together reporting 295.54M shares worth $292M as of Q4 2022.

Institutional Holders
47
Q4 2022
Reported Value
$292M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7

Ownership Trend

Institutional holders
Q4 ’18: 33Q4 ’18Q1 ’19: 36Q1 ’19Q2 ’19: 36Q2 ’19Q3 ’19: 31Q3 ’19Q2 ’21: 34Q2 ’21Q4 ’21: 39Q4 ’21Q4 ’22: 47Q4 ’22filingsflow.com
Total reported value
Q4 ’18: $513MQ4 ’18Q1 ’19: $534MQ1 ’19Q2 ’19: $1.1BQ2 ’19Q3 ’19: $477MQ3 ’19Q2 ’21: $2.9BQ2 ’21Q4 ’21: $8.2BQ4 ’21Q4 ’22: $292MQ4 ’22filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
ABN AMRO INVESTMENT SOLUTIONS$7.7B AUM0.01%$583,500600.0KQ3 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.